Wu, Lian Qiu <br/><br/>
Phenotypic and functional differences between human liver cancer endothelial cells and liver sinusoidal endothelial cells.  [electronic resource] 

 -  Journal of vascular research  2008 
 - 78-86 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0135 
<br/><br/><label>Standard No.: </label>10.1159/000109079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Adhesion<br/>Cell Line<br/>Cell Movement<br/>Cell Proliferation<br/>Cell Shape<br/>Cell Survival<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Endothelial Cells--drug effects<br/>Flow Cytometry<br/>Humans<br/>Integrin alphaVbeta3--genetics<br/>Integrins--genetics<br/>Intercellular Adhesion Molecule-1--genetics<br/>Liver--blood supply<br/>Liver Neoplasms--blood supply<br/>Matrix Metalloproteinases--metabolism<br/>Microcirculation--pathology<br/>Neovascularization, Pathologic--enzymology<br/>Phenotype<br/>Plasminogen Activator Inhibitor 1--metabolism<br/>RNA, Messenger--metabolism<br/>Receptors, Tumor Necrosis Factor, Type II--genetics<br/>Receptors, Vitronectin--genetics<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Thromboplastin--metabolism<br/>Time Factors<br/>Tissue Plasminogen Activator--metabolism<br/>Tumor Necrosis Factor-alpha--pharmacology<br/>Urokinase-Type Plasminogen Activator--metabolism